KLP Kapitalforvaltning’s ADMA Biologics ADMA Stock Holding History

KLP Kapitalforvaltning’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$527K	Hold	52,500	–	–	﹤0.01%	1448
2026 Q2	$439K	Hold	52,500	–	–	﹤0.01%	1558
2026 Q1	$473K	Buy	52,500 +1,500	+3%	+$23.7K	﹤0.01%	1448
2025 Q4	$930K	Buy	51,000 +1,300	+3%	+$21.9K	﹤0.01%	1068
2025 Q3	$729K	Hold	49,700	–	–	﹤0.01%	1207
2025 Q2	$905K	Buy	49,700 +3,400	+7%	+$69.3K	﹤0.01%	1040
2025 Q1	$919K	Hold	46,300	–	–	﹤0.01%	976
2024 Q4	$794K	Buy	+46,300	New	+$871K	﹤0.01%	1095

Other funds holding ADMA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

KLP Kapitalforvaltning's ADMA Position: Q3 2026 in Review

KLP Kapitalforvaltning held its ADMA Biologics (ADMA) position steady in Q3 2026 at 52,500 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

KLP Kapitalforvaltning first reported a position in ADMA in Q4 2024 and has held it in 8 quarters since. The position peaked at $930K in Q4 2025. 262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

KLP Kapitalforvaltning held 52,500 shares of ADMA Biologics worth $527K as of Q3 2026.
KLP Kapitalforvaltning left its ADMA Biologics share count unchanged in Q3 2026.
ADMA Biologics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1448 holding.
KLP Kapitalforvaltning first reported a position in ADMA Biologics in Q4 2024 and has held it in 8 quarters since.
KLP Kapitalforvaltning's ADMA Biologics position peaked at $930K in Q4 2025.
262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.